Mirum Pharmaceuticals, Inc. (MIRM) stock
MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$93.99+0.66 (+0.71%)
Close on Nov 13, 2026Market cap $6.10BP/E –Yield –
Mirum Pharmaceuticals statistics
78 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 24, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 9.17
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 18.6%
- 10.8%
- Shares Change (QoQ)
- 6.28%
- 0.50%
- Float
- 59M
- 49M
- Shares Held by Insiders
- 9.20%
- 11.7%
- Shares Held by Institutions
- 110.0%
- 56.4%
Short sellingIndustry
- Short Interest
- 7M
- –
- Short Interest Change
- -2.09%
- -0.80%
- Short % of Float
- 11.1%
- 9.01%
- Short % of Shares Outstanding
- 10.0%
- 6.30%
- Days to Cover
- 11.84
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $130.00
- –
- 52-Week Low
- $63.23
- –
- 20-Day Moving Average
- $88.34
- –
- 50-Day Moving Average
- $88.79
- –
- 200-Day Moving Average
- $98.41
- –
- Average True Range (14)
- $3.95
- –
- Price Change (1 Week)
- 0.29%
- -1.15%
- Price Change (1 Month)
- 14.1%
- -4.87%
- Price Change (3 Months)
- -5.85%
- -21.0%
- Price Change (6 Months)
- -8.02%
- -20.6%
- Price Change (YTD)
- 19.0%
- -23.6%
- Price Change (1 Year)
- 32.8%
- -22.4%
- Price Change (3 Years)
- 209.9%
- -29.5%
- Price Change (5 Years)
- 491.9%
- -77.9%
- Average Volume (10 Days)
- 649,479
- –
- Average Volume (20 Days)
- 609,763
- –
- Average Volume (90 Days)
- 687,614
- –
- Relative Volume
- 0.48
- 0.70
- Relative Strength Index (14)
- 59.9
- 43.4
- Volatility (1 Year)
- 48.6%
- 80.1%
- Beta (5 Years)
- 0.63
- 1.07
MarginsIndustry
- Pretax Margin
- -138.7%
- -11.6%
- EBITDA Margin
- -130.7%
- -27.7%
- FCF Margin
- -37.0%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -703.0%
- -49.9%
- Return on Assets (ROA)
- -97.2%
- -40.6%
- Return on Capital Employed (ROCE)
- -101.4%
- -37.9%
Financial positionIndustry
- Current Ratio
- 2.86
- 3.30
- Quick Ratio
- 2.62
- 2.39
- Interest Coverage
- -62.06
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 44.0%
- 6.82%
- FCF Growth (YoY)
- -2751.5%
- 6.85%
- Revenue Growth (3Y CAGR)
- 89.1%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.70
- 0.40
- Revenue Per Employee
- $1.66M
- $429.29K
- Profits Per Employee
- -$2.31M
- -$689.41K
- Employee Count
- 372
- 74
- WACC
- 8.26%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$857.54M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $438.29M
- $17.76M
- Net Cash Per Share
- $6.75
- $0.80
- Equity (Book Value)
- -$10.42M
- $53.89M
- Book Value Per Share
- -$0.16
- $1.50
- Tangible Book Value
- -$257.81M
- $27.13M
- Working Capital
- $413.52M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.47M
- -$1.00M
- FCF Per Share
- -$3.52
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -14.1%
- -21.8%
- FCF Yield
- -3.75%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $13.44M
- $2.90M
- Income Tax
- $2.67M
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -0.14
- 0.23
- Piotroski F-Score
- 5
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | MIRM | S&P 500 | Difference | MIRM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +18.0% | -3.0% | +21.1 pts | ||
| 3 months | -4.8% | -2.8% | −2.1 pts | ||
| Year to date | +19.0% | +11.5% | +7.5 pts | ||
| 1 year | +35.7% | +13.5% | +22.3 pts | ||
| 3 years | +208.3% | +77.7% | +130.6 pts | +45.5% | +21.1% |
| 5 years | +491.9% | +72.6% | +419.3 pts | +42.7% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
7M MIRM shares were sold short on Oct 30, 2026, down 2.1% from the previous report, or 11.07% of the shares available to trade. At recent volumes it would take 11.8 days to buy them back. Over the last 20 sessions, 51.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 6,523,716 | -2.1% | 551,116 | 11.8 |
| Oct 15, 2026 | 6,663,045 | -4.6% | 912,849 | 7.3 |
| Sep 30, 2026 | 6,985,385 | +11.2% | 910,920 | 7.7 |
| Sep 15, 2026 | 6,281,413 | +1.8% | 523,889 | 12.0 |
| Aug 31, 2026 | 6,171,979 | -4.9% | 467,192 | 13.2 |
| Aug 14, 2026 | 6,489,383 | -4.9% | 892,852 | 7.3 |
| Jul 31, 2026 | 6,823,706 | -6.2% | 566,260 | 12.1 |
| Jul 15, 2026 | 7,272,892 | -2.8% | 686,482 | 10.6 |
| Jun 30, 2026 | 7,483,286 | +8.3% | 1,491,921 | 5.0 |
| Jun 15, 2026 | 6,909,142 | +5.3% | 614,943 | 11.2 |
| May 29, 2026 | 6,561,290 | -20.0% | 828,272 | 7.9 |
| May 15, 2026 | 8,196,668 | -2.6% | 1,698,609 | 4.8 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?